Junxian Lim

1.5k total citations
42 papers, 1.1k citations indexed

About

Junxian Lim is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Junxian Lim has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Hematology and 10 papers in Immunology. Recurrent topics in Junxian Lim's work include Blood Coagulation and Thrombosis Mechanisms (14 papers), Complement system in diseases (10 papers) and Receptor Mechanisms and Signaling (10 papers). Junxian Lim is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (14 papers), Complement system in diseases (10 papers) and Receptor Mechanisms and Signaling (10 papers). Junxian Lim collaborates with scholars based in Australia, United States and Sweden. Junxian Lim's co-authors include David P. Fairlie, Jacky Y. Suen, Robert C. Reid, Mei‐Kwan Yau, Abishek Iyer, Lindsay Brown, Vernon Seow, Kai‐Chen Wu, Ligong Liu and Rink‐Jan Lohman and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Junxian Lim

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junxian Lim Australia 21 543 275 223 147 138 42 1.1k
John M. Rumberger United States 14 602 1.1× 347 1.3× 183 0.8× 91 0.6× 117 0.8× 20 1.3k
Christoph Kannicht Germany 24 1.0k 1.9× 320 1.2× 397 1.8× 285 1.9× 308 2.2× 65 1.9k
Michael Furlong United States 20 562 1.0× 733 2.7× 145 0.7× 181 1.2× 174 1.3× 31 1.8k
Uma Yasothan United States 22 608 1.1× 287 1.0× 106 0.5× 236 1.6× 433 3.1× 30 1.4k
Silvia Franchini Italy 17 546 1.0× 421 1.5× 134 0.6× 166 1.1× 103 0.7× 56 1.2k
Matthew J. Taylor United States 21 646 1.2× 117 0.4× 231 1.0× 206 1.4× 237 1.7× 33 1.8k
Prosenjit Sen India 18 393 0.7× 140 0.5× 249 1.1× 78 0.5× 66 0.5× 48 953
Ranjini K. Sundaram United States 20 557 1.0× 274 1.0× 149 0.7× 39 0.3× 369 2.7× 45 1.4k
Donald G. Munroe United States 19 787 1.4× 149 0.5× 194 0.9× 60 0.4× 339 2.5× 33 1.9k
Srikumar Sahasranaman United States 18 379 0.7× 193 0.7× 116 0.5× 32 0.2× 359 2.6× 42 1.2k

Countries citing papers authored by Junxian Lim

Since Specialization
Citations

This map shows the geographic impact of Junxian Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxian Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxian Lim more than expected).

Fields of papers citing papers by Junxian Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junxian Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxian Lim. The network helps show where Junxian Lim may publish in the future.

Co-authorship network of co-authors of Junxian Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Junxian Lim. A scholar is included among the top collaborators of Junxian Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junxian Lim. Junxian Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Ligong, Kai‐Chen Wu, Junxian Lim, et al.. (2024). A novel inhibitor of class IIa histone deacetylases attenuates collagen‐induced arthritis. British Journal of Pharmacology. 181(23). 4804–4821. 1 indexed citations
2.
Fairlie, David P., et al.. (2024). Protease-activated receptor 2: A promising therapeutic target for women’s cancers. Journal of Pharmacology and Experimental Therapeutics. 392(1). 100016–100016. 3 indexed citations
3.
Wu, Kai‐Chen, Nicholas D. Condon, Timothy A. Hill, et al.. (2023). Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human Macrophages. Journal of Innate Immunity. 15(1). 468–484. 8 indexed citations
4.
Hill, Timothy A., et al.. (2023). Protease-activated receptor 2 attenuates doxorubicin-induced apoptosis in colon cancer cells. Journal of Cell Communication and Signaling. 17(4). 1293–1307. 7 indexed citations
5.
Lim, Junxian, et al.. (2023). Venom composition and bioactive RF-amide peptide toxins of the saddleback caterpillar, Acharia stimulea (Lepidoptera: Limacodidae). Biochemical Pharmacology. 213. 115598–115598. 7 indexed citations
6.
Wu, Zhixuan, Marina Naval-Sánchez, Xiaoli Chen, et al.. (2022). Temporal perturbation of histone deacetylase activity reveals a requirement for HDAC1–3 in mesendoderm cell differentiation. Cell Reports. 39(7). 110818–110818. 3 indexed citations
7.
Mak, Jeffrey Y. W., Kai‐Chen Wu, Praveer Gupta, et al.. (2021). HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates. Journal of Medicinal Chemistry. 64(4). 2186–2204. 19 indexed citations
8.
Lim, Junxian, Kai‐Chen Wu, Andrew J. Lucke, et al.. (2020). Achiral Derivatives of Hydroxamate AR-42 Potently Inhibit Class I HDAC Enzymes and Cancer Cell Proliferation. Journal of Medicinal Chemistry. 63(11). 5956–5971. 22 indexed citations
9.
Rowley, Jessica A., Robert C. Reid, Kai‐Chen Wu, et al.. (2020). Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory Activity. Journal of Medicinal Chemistry. 63(2). 529–541. 21 indexed citations
10.
Sundström, Linda, Stefan Geschwindner, Yuhong Jiang, et al.. (2020). Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition. Communications Biology. 3(1). 782–782. 29 indexed citations
11.
Lohman, Rink‐Jan, Robert C. Reid, Jessica A. Rowley, et al.. (2017). Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a. Nature Communications. 8(1). 33 indexed citations
12.
Jiang, Yuhong, Mei‐Kwan Yau, Junxian Lim, et al.. (2017). A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells. Journal of Pharmacology and Experimental Therapeutics. 364(2). 246–257. 48 indexed citations
13.
Jiang, Yuhong, Mei‐Kwan Yau, W. Mei Kok, et al.. (2017). Biased Signaling by Agonists of Protease Activated Receptor 2. ACS Chemical Biology. 12(5). 1217–1226. 34 indexed citations
14.
Yau, Mei‐Kwan, Junxian Lim, Ligong Liu, & David P. Fairlie. (2016). Protease activated receptor 2 (PAR2) modulators: a patent review (2010–2015). Expert Opinion on Therapeutic Patents. 26(4). 471–483. 26 indexed citations
15.
Suen, Jacky Y., Mark N. Adams, Junxian Lim, et al.. (2016). Mapping transmembrane residues of proteinase activated receptor 2 (PAR 2 ) that influence ligand-modulated calcium signaling. Pharmacological Research. 117. 328–342. 9 indexed citations
16.
Seow, Vernon, Junxian Lim, Adam J. Cotterell, et al.. (2016). Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists. Scientific Reports. 6(1). 24575–24575. 34 indexed citations
17.
Xu, Weijun, Junxian Lim, Jacky Y. Suen, et al.. (2015). Repurposing Registered Drugs as Antagonists for Protease-Activated Receptor 2. Journal of Chemical Information and Modeling. 55(10). 2079–2084. 8 indexed citations
18.
Perry, Samuel R., Weijun Xu, Junxian Lim, et al.. (2015). Three Homology Models of PAR2 Derived from Different Templates: Application to Antagonist Discovery. Journal of Chemical Information and Modeling. 55(6). 1181–1191. 12 indexed citations
19.
Yau, Mei‐Kwan, Ligong Liu, Junxian Lim, et al.. (2015). Benzylamide antagonists of protease activated receptor 2 with anti-inflammatory activity. Bioorganic & Medicinal Chemistry Letters. 26(3). 986–991. 5 indexed citations
20.
Iyer, Abishek, Andrew Fenning, Junxian Lim, et al.. (2010). Antifibrotic activity of an inhibitor of histone deacetylases in DOCA‐salt hypertensive rats. British Journal of Pharmacology. 159(7). 1408–1417. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John M. Rumberger Breakdown of academic impact, for papers by Christoph Kannicht Breakdown of academic impact, for papers by Michael Furlong Breakdown of academic impact, for papers by Uma Yasothan Breakdown of academic impact, for papers by Silvia Franchini Breakdown of academic impact, for papers by Matthew J. Taylor Breakdown of academic impact, for papers by Prosenjit Sen Breakdown of academic impact, for papers by Ranjini K. Sundaram Breakdown of academic impact, for papers by Donald G. Munroe Breakdown of academic impact, for papers by Srikumar Sahasranaman
Rankless by CCL
2026